What does CUSIP 00771V108 represent in this 13F holders report?

CUSIP 00771V108 is the security identifier for AERI - AERIE PHARMACEUTICALS INC - COM used to aggregate holder disclosures.

How many institutions held AERI - AERIE PHARMACEUTICALS INC - COM in Q1 2021?

157 institutional investors reported AERI - AERIE PHARMACEUTICALS INC - COM for Q1 2021. Use the holders table for investor-level position and value details.

AERIE PHARMACEUTICALS INC - COM (AERI)

CUSIP: 00771V108

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / COM
Total 13F shares: 46,063,476
Share change: +2,123,901
Total reported value: $823,150,946
Put/Call ratio: 176%
Price per share: $17.87
Number of holders: 157
Value change: +$42,521,553
Number of buys: 72
Number of sells: 78

Quarterly Holders Quick Answers

What is CUSIP 00771V108?
CUSIP 00771V108 identifies AERI - AERIE PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 00771V108:

Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021

Institutional Holders of AERIE PHARMACEUTICALS INC - COM (AERI) as of Q1 2021

As of 31 Mar 2021, AERIE PHARMACEUTICALS INC - COM (AERI) was held by 157 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 46,063,476 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., BANK OF AMERICA CORP /DE/, Woodline Partners LP, PFM Health Sciences, LP, LOOMIS SAYLES & CO L P, MORGAN STANLEY, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, AMERIPRISE FINANCIAL INC, and SCHRODER INVESTMENT MANAGEMENT GROUP. This page lists 157 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.